- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, February 3, 2017
Coverage of our peer-reviewed research in the healthcare and mainstream press.
An article in the Fort Wayne, Indiana, News Sentinel discussed the Cologuard colorectal cancer test, which is becoming more popular. It featured the story of a woman who went too long without a colonoscopy even though she was at high risk. The use of an electronic medical record may have prevented this lapse, the article explained, citing a 2010 study from The American Journal of Managed Care® (AJMC®) that explored the effectiveness of interactive health software that searches for gaps in care.
Home Health Care News summarized the findings of a November 2016 AJMC® study, “Does Medicare Advantage Enrollment Affect Home Healthcare Use?” in a recent article. The researchers found that Medicare Advantage beneficiaries use less home health services than their fee-for-service counterparts, but utilization is strongly affected by regional factors.
The National Pharmaceutical Council’s e-newsletter on Thursday highlighted an AJMC® newsroom article contributed by the University of Michigan Center for Value-Based Insurance Design. The article “2016 Year in Review” features an interactive timeline that allows readers to peruse the most important value-based insurance design news of the last year.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
